The Credence Team
The people who carry programs across.
Credence is a bench of eight consultants: scientists, regulators and project leaders with five to twenty years in pharmaceutical development and manufacturing, holding Master’s degrees in Chemistry, B.Pharm and Ph.D. credentials.
8
Consultants on
the bench
the bench
5 to 20 yrs
Industry experience
per consultant
per consultant
9
Compliance projects
completed
completed
5
Ongoing engagements in
Formulation & API
Formulation & API
01 / Leadership
Practitioners first, consultants second.
Every senior advisor at Credence has run the work they now advise on: in R&D leadership, on plant floors and in front of regulators.
Founder & President
Vipan Dhall, Ph.D.
Dr. Dhall founded Credence Pharma Consulting to bring strategic and technical counsel to pharmaceutical, life-sciences and biotech companies, having seen how sharply small and mid-size firms feel the challenges of product and drug-delivery development. Over 25+ years he has taken increasing responsibility across R&D and business operations, serving as CSO of Adare Pharmasolutions and Global R&D Head at Piramal Pharmasolutions while managing teams in the US, UK, Italy and India.
He brings techno-commercial leadership with P&L responsibility across product development, drug discovery and clinical BE, and has been involved in over 100 NCE, 505(b)(2) and generics formulations, including Ciprofloxacin Once-Daily controlled release (Cipro-OD), Tosymra Nasal Spray, Natpara (PTH injection), Gattex (teduglutide injection) and Cinacalcet tablets. He is the inventor on four patents filed to date, and holds a Ph.D. and Master's degree in Pharmaceutical Sciences.
Previously
Adare Pharma · Patheon (ThermoFisher) · Dr. Reddy's · Piramal · Ranbaxy (now Sun Pharma) · NPS Pharmaceuticals (now Takeda) · SGS
Senior Advisor, CMC & API
Dhileep Krishnamurthy, Ph.D., FRSC
Dr. Krishnamurthy is a senior pharmaceutical industry leader advising biotech and CDMO clients across research, development, technology, project management and CMC. Over the past 25 years he has risen from Scientist to VP, Global Head of R&D and CSO across the USA, Germany, India and China, building and strengthening innovator and generics businesses, driving cost reduction in API manufacturing at US FDA-approved plants, and running efficient DMF-ready R&D through competitively advantaged routes using GCbD and QbD.
He co-invented the commercial processes for entecavir and empagliflozin during his years at BMS and Boehringer Ingelheim, and has more than 100 publications, patents and invited presentations. A Fellow of the Royal Society of Chemistry, he serves on the editorial advisory board of Green Chemistry (RSC), judged the US EPA's Presidential Green Chemistry Challenge Award, received Zhejiang Province's West Lake Friendship Award, and advises the Government of India on fermentation and new API technologies. He holds a Ph.D. in Chemistry from the University of Utah and an M.Sc. from IIT Bombay.
Previously
BMS · Boehringer Ingelheim · Dr. Reddy's · Piramal · NHU · Jubilant
Senior Project Manager
Shilpa Cheeti, PMP
Shilpa is a passionate and energetic member of the team, with over 10 years of experience in product development, formulations and project management. She brings a distinctive perspective from both the pharmaceutical and cannabis industries, having worked at Dr. Reddy's and Canopy Growth.
She holds a Master's degree in Pharmacy and is a certified Project Management Professional (PMP), pairing hands-on formulation experience with the planning discipline that keeps development, manufacturing and clinical-BE programs on schedule.
Previously
Dr. Reddy's · Canopy Growth
02 / The Wider Bench
Eight consultants, five to twenty years deep.
Behind the leadership sits a working bench of consultants holding Master’s degrees in Chemistry, B.Pharm and Ph.D. credentials. Nine compliance projects delivered, five engagements running today.
FORMULATION & API
Where we work
Five ongoing engagements across formulation and API manufacturing sites, from green-field plants to brown-field upgrades, alongside nine completed QMS and compliance projects.
FDA · WHO · EU · PIC/S
What we align to
Every system, document and audit-readiness program is built against the regulatory expectations of the FDA, WHO, EU and PIC/S, so the facility passes the inspection it will actually face.
MSC · B.PHARM · PHD
Who does the work
Consultants with five to twenty years in industry, holding Master's degrees in Chemistry, B.Pharm and doctoral credentials. Practitioners who have implemented the systems they now audit.
Put this team on your program.
Whether you are building a green-field facility, remediating a brown-field site or preparing for your next inspection, the bench that has done it before is a conversation away.
Credence Pharma Consulting
Credence
Pharma
Credible partners for pharmaceutical & life-sciences clients. Evidence-led advisory in CMC, regulatory, quality and strategy for NCEs, generics and branded-generics.
© 2026 Credence Pharma Consulting Inc. All rights reserved.